Despite the fact that the GIP hormone was the first insulin-stimulating factor discovered in the 1960s,[34] it demonstrated an impaired insulinotropic effect in patients with type 2 diabetes mellitus (T2DM), disappointing incretin enthusiasts.[35]. This evidence concerns the gene INS and type 2 diabetes mellitus.